Giant Fibroelastoma of the Aortic Valve

Fibroelastomas account for less than 10% of all cardiac tumours, representing the most common valvular and the second most common cardiac benign tumour, following myxomas. Fibroelastomas are histologically benign; they can result in life-threatening complications such as stroke, acute valvular dysf...

Full description

Bibliographic Details
Main Authors: Michele di Summa, Federica Iezzi
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:Case Reports in Cardiology
Online Access:http://dx.doi.org/10.1155/2013/754235
Description
Summary:Fibroelastomas account for less than 10% of all cardiac tumours, representing the most common valvular and the second most common cardiac benign tumour, following myxomas. Fibroelastomas are histologically benign; they can result in life-threatening complications such as stroke, acute valvular dysfunction, embolism, ventricular fibrillation, and sudden death. Surgical resection should be offered to all patients who have symptoms and to asymptomatic patients who have pedunculated lesions or tumors larger than 1 cm in diameter. Valve-sparing excision produces good long-term results in most instances. We report our surgical experience of a giant fibroelastoma in the aortic valve.
ISSN:2090-6404
2090-6412